FindTrial
Sign In

To study the occurrence of acute kidney disease in patients with preeclampsia admitted to the ICU

Acute Kidney Injury in Critically ill Preeclamptic patients: Epidemiology and Role of Serum NGAL- A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016617
Enrollment
48
Registered
2018-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O142- HELLP syndrome Health Condition 2: O140- Mild to moderate pre-eclampsia Health Condition 3: O141- Severe pre-eclampsia Health Condition 4: O149- Unspecified pre-eclampsia

Interventions

None listed

Sponsors

University College of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All preeclamptic obstetric patients (pregnant or within 6 weeks post-delivery), admitted to our multidisciplinary ICU with an anticipated stay of greater than 24 hours will be included.

Exclusion criteria

Exclusion criteria: Those not requiring insertion of a Foleyâ??s catheter, or with history of renal dysfunction or requirement of renal replacement therapy prior to present hospitalization, or with renal transplant will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Occurrence of Acute Kidney InjuryTimepoint: Patients will be assessed for Acute Kidney injury everyday till Patient is in ICU.—

Secondary

MeasureTime frame
The role of serum NGAL for prediction of AKITimepoint: At the time of ICU admission—

Countries

India

Contacts

Public ContactDr Pooja Yadav

University College of Medical Sciences and GTB Hospital, Delhi

drashatyagi@gmail.com9818606404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026